Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2001;7(5):421–431. doi: 10.1080/135502801753170273

Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence

Joanna J Phillips 1, MingMing Chua 1, Su-hun Seo 1, Susan R Weiss 1,✉
PMCID: PMC7095106  PMID: 11582514

Abstract

The spike (S) glycoprotein of mouse hepatitis virus (MHV) is a major determinant of neurovirulence. Using targeted recombination we previously demonstrated that the S gene of the highly neurovirulent MHV-4 conferred a dramatic increase in neurovirulence to the mildly neurovirulent MHV-A59. To identify the genetic determinants of neurovirulence within the MHV-4 spike, we generated isogenic recombinant viruses containing various MHV-4/MHV-A59 chimeric spike genes, and studied their phenotypes in vivo. The MHV-4/MHV-A59 chimeric spike genes consisted of either reciprocal exchanges between the S1 and S2 spike subunits, or smaller exchanges specifically in the hyper-variable region (HVR) of S1. The chimeric spike gene containing recombinants all exhibited efficient replication in vitro, yet many were severely attenuated for virulence in vivo. Furthermore, these attenuated recombinants exhibited decreased titers of infectious virus in the brain relative to the parental recombinant viruses containing the full-length MHV-4 or MHV-A59 spike genes. This is the first report that compares the neurovirulence and pathogenesis of isogenic viruses with defined alterations in the MHV spike protein. From these studies, it appears that the interactions of multiple regions of the MHV spike, including the HVR, act in concert to allow for efficient infection of and virulence in the murine central nervous system.

Keywords: mouse hepatitis virus, encephalitis, recombinant coronaviruses, neurovirulence

References

  1. Banner LR, Keck JG, Lai MMC. A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology. 1990;175:548–555. doi: 10.1016/0042-6822(90)90439-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beauchemin N, Draber P, Dveksler G, Gold P, Gray-Owen S, Grunert F, Hammarstrom S, Holmes KV, Karlsson A, Kuroki M, Lin S-H, Lucka L, Najjar SM, Neumaier M, Obrink B, Shively JE, Skubitz KM, Stanners CP, Thomas P, Thompson JA, Virji M, von Kleist S, Wagener C, Watt S, Zimmermann W. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res. 1999;252:243–249. doi: 10.1006/excr.1999.4610. [DOI] [PubMed] [Google Scholar]
  3. Bergmann CC, Yao Q, Lin M, Stohlman SA. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J Gen Virol. 1996;77:315–325. doi: 10.1099/0022-1317-77-2-315. [DOI] [PubMed] [Google Scholar]
  4. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984;132:261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Castro RF, Perlman S. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol. 1995;69:8127–8131. doi: 10.1128/jvi.69.12.8127-8131.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collins AR, Knobler RL, Powell H, Buchmeier MJ. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 1982;119:358–371. doi: 10.1016/0042-6822(82)90095-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dalziel RG, Lampert PW, Talbot PJ, Buchmeier MJ. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J Virol. 1986;59:463–471. doi: 10.1128/jvi.59.2.463-471.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DeGroot RJ, Luytjes W, Horzinek MC, van der Zeijst BAM, Spaan WJM, Lenstra JA. Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol. 1987;196:963–966. doi: 10.1016/0022-2836(87)90422-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang G-S, Hohnes KV, Dieffenbach CW. Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hampster cell lines confers susceptibility to MHV. J Virol. 1991;65:6881–6891. doi: 10.1128/jvi.65.12.6881-6891.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fazakerley JK, Parker SE, Bloom F, Buchmeier MJ. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 1992;187:178–188. doi: 10.1016/0042-6822(92)90306-A. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fischer F, Stegen CF, Koetzner CA, Masters PS. Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J Virol. 1997;71:5148–5160. doi: 10.1128/jvi.71.7.5148-5160.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fleming JO, Stohlman SA, Harmon RC, Lai MMC, Frelinger JA, Weiner LP. Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology. 1983;131:296–307. doi: 10.1016/0042-6822(83)90498-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fleming JO, Trousdale MD, El-Zaatari FAK, Stohlman SA, Weiner LP. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol. 1986;58:869–875. doi: 10.1128/jvi.58.3.869-875.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Frana MF, Behnke JN, Sturman LS, Holmes KV. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Host-dependent differences in proteolytic cleavage and cell fusion. J Virol. 1985;56:912–920. doi: 10.1128/jvi.56.3.912-920.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gallagher TM. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J Virol. 1997;71:3129–3137. doi: 10.1128/jvi.71.4.3129-3137.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gallagher TM, Buchmeier MJ, Perlman S. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology. 1992;191:517–522. doi: 10.1016/0042-6822(92)90223-C. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gallagher TM, Escarmis C, Buchmeier MJ. Alteration of pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J Virol. 1991;65:1916–1928. doi: 10.1128/jvi.65.4.1916-1928.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gallagher TM, Parker SE, Buchmeier MJ. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the aminoterminal half of the spike glycoprotein. J Virol. 1990;64:731–741. doi: 10.1128/jvi.64.2.731-741.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gombold JL, Hingley ST, Weiss SR. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J Virol. 1993;67:4504–4512. doi: 10.1128/jvi.67.8.4504-4512.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Grosse B, Siddell SG. Single amino acid changes in the S2 subunit of the MHV surface glycoprotein confer resistance to neutralization by S1 subunit-specific mon oclonal antibody. Virology. 1994;202:814–824. doi: 10.1006/viro.1994.1403. [DOI] [PubMed] [Google Scholar]
  21. Hingley ST, Gombold JL, Lavi E, Weiss SR. MHV A59 fusion mutants are attenuated and display altered hepatotropism. Virology. 1994;200:1–10. doi: 10.1006/viro.1994.1156. [DOI] [PubMed] [Google Scholar]
  22. Koetzner CA, Parker MM, Ricard CS, Sturman LS, Masters PS. Repair and mutagenesis of the genome of a deletion mutant of the murine coronavirus mouse hepatitis virus by targeted RNA recombination. J Virol. 1992;66:1841–1848. doi: 10.1128/jvi.66.4.1841-1848.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kubo H, Yamada YK, Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol. 1994;68:5404–5410. doi: 10.1128/jvi.68.9.5403-5410.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kuo L, Godeke G-J, Raamsman MJB, Masters PS, Rottier PJM. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: Crossing the host cell species barrier. J Virol. 2000;74:1393–1406. doi: 10.1128/JVI.74.3.1393-1406.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lavi E, Fishman PS, Highkin MK, Weiss SR. Limbic encephalitis after inhalation of a murine coronavirus. Lab Investig. 1988;58:31–36. [PubMed] [Google Scholar]
  26. Lavi E, Gilden DH, Highkin MK, Weiss SR. The organ tropism of mouse hepatitis virus strain A59 is dependent on dose and route of inoculation. Lab Anim Sci. 1986;36:130–135. [PubMed] [Google Scholar]
  27. Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol. 1998;72:9628–9636. doi: 10.1128/jvi.72.12.9628-9636.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Luytjes W, Sturman LS, Bredenbeck PJ, Charite J, van der Zeijst BAM, Horzinek MC, Spaan WJM. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology. 1987;161:479–487. doi: 10.1016/0042-6822(87)90142-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning, a laboratory manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory; 1982. [Google Scholar]
  30. Masters PS, Koetzner CA, Kerr CA, Heo Y. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J Virol. 1994;68:328–337. doi: 10.1128/jvi.68.1.328-337.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Parker SE, Gallagher TM, Buchmeier MJ. Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology. 1989;173:664–673. doi: 10.1016/0042-6822(89)90579-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity. 1996;5:253–262. doi: 10.1016/S1074-7613(00)80320-9. [DOI] [PubMed] [Google Scholar]
  33. Phillips JJ, Chua MM, Lavi E, Weiss SR. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. J Virol. 1999;73:7752–7760. doi: 10.1128/jvi.73.9.7752-7760.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pritchard AE, Jensen K, Lipton HI. Assembly of Theiler’s virus recombinants used in mapping determinants of neurovirulence. J Virol. 1993;67:3901–3907. doi: 10.1128/jvi.67.7.3901-3907.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ramig RF. Isolation and genetic characterization of temperature sensitive mutants of simian rotavirus SA11. Virology. 1982;120:93–135. doi: 10.1016/0042-6822(82)90009-5. [DOI] [PubMed] [Google Scholar]
  36. Rao PV, Gallagher TM. Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections. J Virol. 1998;72:3278–3288. doi: 10.1128/jvi.72.4.3278-3288.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Reed LJ, Muench H. A simple method of estimating fifty per cent points. Am J Hygeine. 1938;27:493–497. [Google Scholar]
  38. Saeki K, Ohtsuka N, Taguchi F. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resisitant mutants. J Virol. 1997;71:9024–9031. doi: 10.1128/jvi.71.12.9024-9031.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Smith AL, Barthold SW. Methods in viral pathogenesis. In: Nathanson N, editor. Viral pathogenesis. Philadelphia, Pennsylvania: Lippincott-Raven; 1997. pp. 483–506. [Google Scholar]
  40. Sturman LS, Ricard CS, Holmes KV. Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37°C correlates with virus aggregation and virus-induced cell fusion. J Virol. 1990;64:3042–3050. doi: 10.1128/jvi.64.6.3042-3050.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Taguchi F, Fleming JO. Comparison of six different murine coronavirus JHM variants by monoclonal antibodies against the E2 glycoprotein. Virology. 1989;169:233–235. doi: 10.1016/0042-6822(89)90061-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tsai C-W, Chang SC, Chang M-F. A 12-amino acid stretch in the hypervariable region of the spike protein S1 subunit is critical for cell fusion activity of mouse hepatitis virus. J Biol Chem. 1999;274:26085–26090. doi: 10.1074/jbc.274.37.26085. [DOI] [PubMed] [Google Scholar]
  43. Wang F-I, Fleming JO, Lai MMC. Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology. 1992;186:742–749. doi: 10.1016/0042-6822(92)90041-M. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wege H, Winter J, Meyermann R. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: Definition of critical epitopes by variant analysis. J Gen Virol. 1988;69:87–98. doi: 10.1099/0022-1317-69-1-87. [DOI] [PubMed] [Google Scholar]
  45. Weismiller DG, Sturman LS, Buchmeier MJ, Fleming JO, Holmes KV. Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions. J Virol. 1990;64:3051–3055. doi: 10.1128/jvi.64.6.3051-3055.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Williams RK, Jiang GS, Holmes KV. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci USA. 1991;88:5533–5536. doi: 10.1073/pnas.88.13.5533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Zhang L, Senkowski A, Shim B, Roos RP. Chimeric cDNA studies of Theiler’s murine encephalomyelitis virus neurovirulence. J Virol. 1993;67:4404–4408. doi: 10.1128/jvi.67.7.4404-4408.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurovirology are provided here courtesy of Nature Publishing Group

RESOURCES